JPS635036A - Squalene-containing composition - Google Patents

Squalene-containing composition

Info

Publication number
JPS635036A
JPS635036A JP14898286A JP14898286A JPS635036A JP S635036 A JPS635036 A JP S635036A JP 14898286 A JP14898286 A JP 14898286A JP 14898286 A JP14898286 A JP 14898286A JP S635036 A JPS635036 A JP S635036A
Authority
JP
Japan
Prior art keywords
squalene
containing composition
antioxidant
phospholipid
phospholipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP14898286A
Other languages
Japanese (ja)
Inventor
Michio Nakanishi
中西 美智夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP14898286A priority Critical patent/JPS635036A/en
Publication of JPS635036A publication Critical patent/JPS635036A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a squalene-containing composition useful as a nutrient assistant and pharmaceutical, etc., by adding a phospholipid to squalene, thereby stabilizing squalene. CONSTITUTION:Squalene is a compound having the chain structure of formula, high impregnation property and activation activity and exhibiting effective physiological action to gastric ulcer and hepatic diseases, however, it has poor stability and is liable to be easily decomposed with oxygen or heat owing to its highly unsaturated structure. The objective stabilized squalene-containing composition can be produced by compounding (A) 100pts.wt. of squalene with (B) preferably about >=1pt., especially about >=3pts.wt. of one or more kinds of phospholipids selected from phosphatidylcholine, phosphatidyl ethanolamine, sphingomyelin, etc., as a stabilizer for the component A and preferably further (C) preferably 1-10pts.wt. of an antioxidant, especially a natural antioxidant such as vegetable oil containing tocopherol.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は安定なスクアレン含有組成物に関する。[Detailed description of the invention] [Industrial application field] The present invention relates to stable squalene-containing compositions.

〔従来技術・発明が解決しようとする問題点〕スクアレ
ンは6個のイソプレン残基からなる炭素数30の鎖状構
造をもつ化合物であり、サメ類の肝油などに含まれる無
色の油状物で、深海鮫から取れるところからGiWj鮫
エキスとも呼ばれる。
[Prior art/problems to be solved by the invention] Squalene is a compound with a chain structure of 30 carbon atoms consisting of 6 isoprene residues, and is a colorless oily substance found in shark liver oil. It is also called GiWj shark extract because it is extracted from deep-sea sharks.

近年スクアレンは、1916年に発見され、主として化
粧品原料として使用されてきたが、1974年になり、
栄養補助食品としての地位を占めるようになった。
In recent years, squalene was discovered in 1916 and has been mainly used as a cosmetic raw material, but in 1974,
It has come to be considered a dietary supplement.

スクアレンの生理作用としては、たとえば次のごときも
のが例示される。
Examples of the physiological effects of squalene include the following.

(1)  浸透性、賦活作用に冨み、胃潰瘍などの疾患
に効果を有し、 (2)肝臓疾患に有効(これは病んだ細胞に酸素を送り
、賦活性を与えるものではないかと考えられる)、 (3)細胞に酸素を運ぶ働きを有し、細胞に活力を与え
る ところがスクアレンは高度な不飽和化合物であることか
ら安定性が悪く、酸素や熱等によって容易に劣化してし
まうことが問題点とされている。
(1) Rich in permeability and activating effect, effective against diseases such as gastric ulcers; (2) Effective against liver diseases (this is thought to be a substance that sends oxygen to diseased cells and gives them activation) (3) Squalene has the function of transporting oxygen to cells and gives them vitality, but as it is a highly unsaturated compound, it has poor stability and is easily degraded by oxygen, heat, etc. is considered to be a problem.

従って、本発明の目的は、スクアレンの安定な組成物を
提供することである。
It is therefore an object of the present invention to provide stable compositions of squalene.

〔問題点を解決するための手段〕[Means for solving problems]

本発明者はスクアレンの安定化について種々研究を重ね
てきたところ、リン脂質がスクアレンに対する安定化作
用を有することを見出し、本発明を完成した。
The present inventor has conducted various studies on the stabilization of squalene, and has discovered that phospholipids have a stabilizing effect on squalene, and has completed the present invention.

即ち、本発明は、スクアレンの安定化剤として、リン脂
質から選ばれる少なくとも一種を配合してなることを特
徴とするスクアレン含有組成物に関するものであり、ま
た、本発明は当該組成物にさらに抗酸化剤を配合してな
るスクアレン含有組成物に関する。
That is, the present invention relates to a squalene-containing composition characterized in that it contains at least one type selected from phospholipids as a squalene stabilizer, and the present invention also relates to a squalene-containing composition that is characterized by containing at least one type selected from phospholipids as a squalene stabilizer. The present invention relates to a squalene-containing composition containing an oxidizing agent.

スクアレンは6個のイソプレン残基からなる下記構造式 で表される鎖状構造を持つ。Squalene has the following structural formula consisting of 6 isoprene residues. It has a chain structure represented by .

スクアレンは高純度のものを使用するのが望ましく、組
成物中には20重量%以上、好ましくは30重量%以上
含有される。
It is desirable to use squalene of high purity, and it is contained in the composition in an amount of 20% by weight or more, preferably 30% by weight or more.

本発明で安定化剤として使用されるリン脂質は、リンを
有する脂質の総称であり、グリセライドを基本骨格とし
たものや、そうでないものがあり、脂肪酸残基を1〜2
個有している。たとえばホスファチジルコリン、ホスフ
ァチジルエタノールアミン、スフィンゴミエリン等が例
示される。本発明で使用されるリン脂質は、上記リン脂
質単独は勿論のこと、上記リン脂質の混合物、上記リン
脂質含有物の態様で使用してもよい。特にレシチン(例
えば、大豆レシチン、卵黄レシチン)、水素添加レシチ
ン等の態様で使用することが好ましい。
The phospholipid used as a stabilizer in the present invention is a general term for lipids containing phosphorus, and there are those that have a basic skeleton of glyceride and those that do not, and that have one to two fatty acid residues.
I have one. Examples include phosphatidylcholine, phosphatidylethanolamine, and sphingomyelin. The phospholipid used in the present invention may be used not only as the above-mentioned phospholipid alone, but also in the form of a mixture of the above-mentioned phospholipids, or a product containing the above-mentioned phospholipids. In particular, it is preferable to use lecithin (eg, soybean lecithin, egg yolk lecithin), hydrogenated lecithin, and the like.

本発明の組成物においてはスクアレン100重量部に対
し、リン脂質(例えばレシチン)は1重量部程度以上、
特に3重量部程度以上加えることが好ましい。
In the composition of the present invention, the phospholipid (for example, lecithin) is about 1 part by weight or more per 100 parts by weight of squalene.
In particular, it is preferable to add about 3 parts by weight or more.

本発明は、さらに抗酸化剤を配合してなる組成物を提供
するものである。抗酸化剤としては、天然抗酸化剤が好
ましく、たとえばトコフェロール類等の植物油、フラボ
ン誘導体、没食子酸誘導体、カテキン酸、ステロール類
、テルペン類またはこれらを含有する植物抽出物等が挙
げられる。トコフェロール類含有植物としては、たとえ
ば小麦胚芽、綿の実、大豆等、フラボン誘導体含有植物
としては、たとえばサクラソウ属に属するもの、ジキタ
リス、甘草等、没食子酸誘導体含有物としては、たとえ
ば五倍子、没食子等、カテキン酸含有植物としては、た
とえばユーカリ属、ウルシ属の樹木等、ステロール類含
有植物としては、たとえばアブラナ、酵母、大豆等が例
示される。
The present invention provides a composition further containing an antioxidant. The antioxidant is preferably a natural antioxidant, such as vegetable oils such as tocopherols, flavone derivatives, gallic acid derivatives, catechic acid, sterols, terpenes, or plant extracts containing these. Examples of plants containing tocopherols include wheat germ, cottonseed, soybeans, etc.; examples of plants containing flavone derivatives include those belonging to the genus Primrose, digitalis, licorice, etc.; examples of plants containing gallic acid derivatives include pentagrams, galls, etc. Examples of catechic acid-containing plants include trees of the genus Eucalyptus and Ursica, and examples of sterol-containing plants include rapeseed, yeast, and soybean.

抗酸化剤はスクアレン100重量部に対して1〜10重
量部配合されることが望ましい。
It is desirable that the antioxidant be blended in an amount of 1 to 10 parts by weight per 100 parts by weight of squalene.

本発明の組成物においては、リン脂質、抗酸化剤に加え
て、更にリン脂質を溶解する物質、特にリン脂質および
スクアレンを溶解する物質を配合してもよい。熔解補助
剤としては、上記の抗酸化剤であるトコフェロール等の
植物油、テルペン類を含有する柑橘類抽出物を溶解補助
剤と兼ねて使用してもよく、他には植物油(米油、綿実
油、コーン油等)、有機溶媒、蛋白質分解物(コラーゲ
ン加水分解物等、好ましくは分子量1000〜3000
程度のもの等)を配合してもよい、当該物質の配合量は
、スクアレン及びリン脂質を溶解するに足る1以上であ
ればよい。
In addition to phospholipids and antioxidants, the composition of the present invention may further contain a substance that dissolves phospholipids, particularly a substance that dissolves phospholipids and squalene. As the solubilizing agent, vegetable oils such as tocopherols, which are antioxidants mentioned above, and citrus extracts containing terpenes may also be used as solubilizing agents. oil, etc.), organic solvent, protein decomposition product (collagen hydrolyzate, etc., preferably with a molecular weight of 1000 to 3000)
The amount of the substance may be one or more sufficient to dissolve squalene and phospholipid.

本発明組成物にはさらにリン酸、クエン酸、アスコルビ
ン酸、メラノイジン、核酸、フェラル酸エステル等を配
合することにより、スクアレンの安定化が促進される。
Stabilization of squalene is promoted by further blending phosphoric acid, citric acid, ascorbic acid, melanoidin, nucleic acid, feral acid ester, etc. into the composition of the present invention.

本発明の組成物は食品、栄養補助剤、医薬品等として使
用されるものである。かかる製品は、たとえば蜜ろう、
乳糖等を配合し、常套手段によって調製することが出来
る。
The composition of the present invention is used as a food, a nutritional supplement, a pharmaceutical, and the like. Such products include, for example, beeswax,
It can be prepared by conventional means by blending lactose and the like.

〔実施例・実験例〕[Example/Experiment example]

実施例1〜5 以下の表1で示される組成を均質になるまで混合し、ス
クアレン含有組成物を製造した。なお表中の数字は重量
部を示す。
Examples 1 to 5 The compositions shown in Table 1 below were mixed until homogeneous to produce squalene-containing compositions. Note that the numbers in the table indicate parts by weight.

(以下余白) 表   1 比較例1 スクアレン単品の製剤を作製した。(Margin below) Table 1 Comparative example 1 A single squalene formulation was prepared.

比較例2 スクアレン100重量部およびビタミンE2重量部から
なる組成物を作製した。
Comparative Example 2 A composition consisting of 100 parts by weight of squalene and 2 parts by weight of vitamin E was prepared.

実験例1 実施例1〜5および比較例1.2の製剤を使用し、60
℃の恒温水浴中に蓋をせずに放置後、−定時間毎にその
一部を採取し、そこに含まれる過酸化物を定量し、過酸
化物価を求め、その結果を表2に示した。なお、表中の
括弧内の数字は0時間の数値をOとし、各測定時の過酸
化物価の変動を示す。
Experimental Example 1 Using the formulations of Examples 1 to 5 and Comparative Example 1.2, 60
After leaving it uncovered in a constant temperature water bath at ℃, a portion of it was sampled at regular intervals, the peroxide contained therein was quantified, and the peroxide value was determined. The results are shown in Table 2. Ta. Note that the numbers in parentheses in the table indicate the change in peroxide value at each measurement time, with the value at 0 hours being O.

過酸化物の定量方法および過酸化物価の求め方:試料1
0gを共セン付三角フラスコに正しく採取し、溶剤(ク
ロロホルム2:氷酢酸3)60−を加え、静かに振りま
ぜて透明に溶かす。
Method for quantifying peroxide and determining peroxide value: Sample 1
0 g was properly collected in an Erlenmeyer flask with a co-sensor, 60 - of a solvent (chloroform: 2: glacial acetic acid: 3) was added, and the mixture was gently shaken to dissolve it into a transparent solution.

飽和ヨウ化カリウム溶液in/を加え、直ちに共センを
して1分間振りまぜ、水60I117を加え、デンプン
溶液を指示薬として、0.0INチオ硫酸ナトリウム溶
液で滴定する。デンプンによる着色が消失するときを終
点とする。空試験を並行して行う。
Add saturated potassium iodide solution in/and immediately mix for 1 minute, add 60I117 of water, and titrate with 0.0IN sodium thiosulfate solution using starch solution as an indicator. The end point is when the coloring caused by starch disappears. A blank test will be conducted in parallel.

過酸化物価は次の式で求められる。The peroxide value is determined by the following formula.

過酸化物価(■当量/kg)=(A−B)XFX10+
CA−本試験のチオ硫酸ナトリウム溶液使用量(a/)
B=空試験のチオ硫酸ナトリウム溶液使用量(−)C=
試料採取量(g) F=チオ硫酸ナトリウム溶液の力価 (余白) 」 〔効果〕 リン脂質はスクアレンに対して優れた安定他作Mを有す
る。従って、スクアレンにリン脂質を配きした組成物は
、そこに含まれるスクアレンが安?に存在する。
Peroxide value (■equivalent/kg) = (A-B)XFX10+
CA-Amount of sodium thiosulfate solution used in this test (a/)
B = Amount of sodium thiosulfate solution used in blank test (-) C =
Amount of sample collected (g) F = Potency of sodium thiosulfate solution (margin) [Effect] Phospholipid has excellent stability against squalene. Therefore, in compositions in which phospholipids are added to squalene, is the squalene contained therein cheap? exists in

し二白Shinihaku

Claims (2)

【特許請求の範囲】[Claims] (1)スクアレンの安定化剤として、リン脂質から選ば
れる少なくとも一種を配合してなることを特徴とするス
クアレン含有組成物。
(1) A squalene-containing composition comprising at least one selected from phospholipids as a squalene stabilizer.
(2)さらに抗酸化剤を配合してなる特許請求の範囲第
(1)項記載の組成物。
(2) The composition according to claim (1), further comprising an antioxidant.
JP14898286A 1986-06-25 1986-06-25 Squalene-containing composition Pending JPS635036A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14898286A JPS635036A (en) 1986-06-25 1986-06-25 Squalene-containing composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14898286A JPS635036A (en) 1986-06-25 1986-06-25 Squalene-containing composition

Publications (1)

Publication Number Publication Date
JPS635036A true JPS635036A (en) 1988-01-11

Family

ID=15465045

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14898286A Pending JPS635036A (en) 1986-06-25 1986-06-25 Squalene-containing composition

Country Status (1)

Country Link
JP (1) JPS635036A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2834639A1 (en) * 2002-01-11 2003-07-18 Medix Lab Topically applied dermatological or cosmetic composition, used e.g. for promoting skin regeneration and treating edema, contains flavonoid and vegetable oil containing linoleic and/or alpha-linolenic acid
ES2275435A1 (en) * 2005-11-18 2007-06-01 Farmaleis, S.L. A combination comprising squalene, a phospholipid and an omega 3 fatty acid for the treatment of cancer
JP2011144134A (en) * 2010-01-15 2011-07-28 Tosoh Finechem Corp Diethylzinc composition, heat stabilization method, and compound for use in heat stabilization
KR20200091896A (en) 2017-12-06 2020-07-31 가부시키가이샤 사카타노타네 Production method of lactoca plant seeds using scissors bee

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2834639A1 (en) * 2002-01-11 2003-07-18 Medix Lab Topically applied dermatological or cosmetic composition, used e.g. for promoting skin regeneration and treating edema, contains flavonoid and vegetable oil containing linoleic and/or alpha-linolenic acid
ES2275435A1 (en) * 2005-11-18 2007-06-01 Farmaleis, S.L. A combination comprising squalene, a phospholipid and an omega 3 fatty acid for the treatment of cancer
JP2011144134A (en) * 2010-01-15 2011-07-28 Tosoh Finechem Corp Diethylzinc composition, heat stabilization method, and compound for use in heat stabilization
KR20200091896A (en) 2017-12-06 2020-07-31 가부시키가이샤 사카타노타네 Production method of lactoca plant seeds using scissors bee

Similar Documents

Publication Publication Date Title
JP3005226B2 (en) Method for producing antioxidant mixture
JP3103430B2 (en) Fat-soluble antioxidant mixture
EP0180786B2 (en) Pharmaceutical or dietetic composition having a high antithrombotic and antiarteriosclerotic activity
US9301536B2 (en) Antioxidant composition for marine oils comprising tocopherol, rosemary extract, ascorbic acid and green tea extract
US5258179A (en) Protection of a food, cosmetic or pharmaceutical product against oxidation
DE60317639T2 (en) COMPOSITIONS CONTAIN N-ACYL-PHOSPHATIDYL-ETHANOLAMINE AND / OR MIXTURES OF N-ACYL-ETHANOLAMINES WITH PHOSPHATIDINIC ACIDS OR LYSOPHOSPHATIDINIC ACIDS
EP0084341B1 (en) Emulsion-type composition for external use
JP3081226B2 (en) Method for preventing oxidation of fats or fat-containing products
EP0577305B1 (en) Antioxidant compositions
JPS635036A (en) Squalene-containing composition
JPS60192547A (en) Edible liquid compounded oil
JP3715345B2 (en) Method of adding water-soluble active ingredients to fat
JP2001122884A (en) Method for producing oil-soluble composition having high content of phosphatidyl serine
EP0303970B1 (en) Surfactant composition having improved functions
JP3550176B2 (en) Tocopherol-enriched refined sesame oil, fat infusion containing it and oral preparation
JPS60192546A (en) Edible liquid compounded oil
JPS62187425A (en) Composition containing linolenic acid and its derivative
JPS5944357B2 (en) Antioxidant
WO1987007263A1 (en) Composition containing linolenic acid compound
JP2020150822A (en) Oils and fats, method for producing oils and fats, and oxidation inhibitor for oils and fats
Gunstone Scottish Crop Research Institute, Invergowrie, Dundee, Scotland
JPH01307437A (en) Safe lipid composition having high surface activity